Functionally selective ALPHA2C adrenoreceptor agonists
US8003624B2 · kind B2 · utility
11Cited by
4References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 13, 2007 |
| Grant date | Aug 23, 2011 |
| Priority date | — |
| Expiry date | Feb 13, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In its many embodiments, the present invention provides a novel class of indolines as inhibitors of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.